Phillip Frost

From SourceWatch
Jump to: navigation, search

A report from 2018 noted: "Frost, formerly chairman of Teva Pharmaceuticals is one of 10 individuals accused of long-running microcap 'pump-and-dump' schemes... Frost is chairman and CEO of OPKO, a dual listed company traded in Tel Aviv and Wall Street. Frost served until 2014 as chairman of generic drug giant Teva Pharmaceuticals. Frost joined Teva in 2006 as a board member, after the drug giant bought control of Frost’s company Ivax for $7.4 billion. Frost was appointed board chairman in 2010 in place of long-term chairman Eli Hurvitz, who resigned due to his declining health." [1]

"He served as a Director from May 2001 to July 2002 at Ladenburg Thalmann Financial Services Inc. He served as Director from September 2005 to September 12, 2007 at Castle Brands Inc. He served as a Member of Scientific Advisory Board at MusclePharm Corporation. He served as an Independent Director of Continucare Corporation since January 2004. He served as a Director of PROLOR Biotech, Inc. since May 2007. He served as a Director of North American Vaccine since October 1989, ERBA Diagnostics, Inc., from 2001 to April 2006, Orthodontix Inc., since January 03, 2007, Cellular Technical Services Co. Inc. since April 12, 2005 and Protalix BioTherapeutics, Inc., from December 31, 2006 to December 2007. He served as a Director of Teva Pharmaceutical Industries Limited from 2006 to February 4, 2015. He served as a Director of American Exploration Company from 1983 to 1998 and Northrup Grumman Corporation from 1996 to May 20, 2009. He served as a Director of TransEnterix, Inc. since 2013. He served as a Member of Board of Regents of Smithsonian Institution from 2006 to 2010. He served as a Director of Teva Czech Industries s.r.o. He served as a Director of SafeStitch Medical, Inc., since 2005. He served as a Director of Northrop Grumman Corporation from 1996 to May 20, 2009, Pan Am Corporation since March 8, 1996 and IVAX LLC since 1987. He served as a Director of GBI Capital Management Corp., IVAX-CR AS and IVAX Pharmaceuticals s.r.o. " [1]

Resources and articles

Related Sourcewatch

References

  1. Haaretz U.S. Securities and Exchange Commission Charges OPKO's Phillip Frost With Stock Fraud, organizational web page, accessed October 8, 2018.